Cointime

IntegraGen

company

About

IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.

  • 11 - 50

Highlights

Total Funding Amount
€8M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
€8M
Industries
Biotechnology,Genetics,Health Care,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€8M
IntegraGen has raised a total of €8M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2005 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 17, 2005 Series B €8M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
IntegraGen is funded by 1 investors. Bioam Gestion are the most recent investors.
Investor Name Lead Investor Funding Round
Bioam Gestion — Series B
Cointime
เนื้อหา
บริษัท